SCHEDULE 13G/A: Perceptive Advisors Discloses 6.4% Passive Stake in Evolus, Inc.
Beneficial Ownership Disclosure
Perceptive Advisors LLC and its affiliates have filed an amended Schedule 13G, reporting a continued passive beneficial ownership of 6.4% in Evolus, Inc.'s common stock.
Summary
- Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. (collectively, the "Reporting Persons") have filed an Amendment No. 3 to Schedule 13G.
- The filing discloses beneficial ownership of 4,129,142 shares of Evolus, Inc. common stock.
- This represents 6.4% of Evolus, Inc.'s outstanding common stock.
- The ownership percentage is based on 64,475,589 shares of common stock outstanding as of May 2, 2025, as reported in Evolus, Inc.'s Quarterly Report on Form 10-Q filed on May 7, 2025.
- The Master Fund directly holds all 4,129,142 shares.
- Perceptive Advisors serves as the investment manager to the Master Fund, and Joseph Edelman is the managing member of Perceptive Advisors.
- The Reporting Persons share both voting and dispositive power over all 4,129,142 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of Evolus, Inc., indicating a passive investment intent.
Sentiment
Score: 5
Explanation: The document is a factual, routine disclosure of beneficial ownership and does not contain information that would inherently suggest positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
NA
Industry Context
This filing is a routine disclosure by an institutional investor, Perceptive Advisors, indicating its passive stake in Evolus, Inc., a company in the biopharmaceutical or aesthetics industry. Such disclosures are common for investment firms holding significant, non-controlling positions in public companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's passive stake, which can offer some stability or confidence in the stock's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement |
| 05/02/2025 | Date as of which 64,475,589 shares of Common Stock were reported outstanding by Evolus, Inc. |
| 05/07/2025 | Date Evolus, Inc. filed its Quarterly Report on Form 10-Q, reporting outstanding shares |
| 05/15/2025 | Date of signing of the Schedule 13G Amendment No. 3 |
Keywords
Evolus Inc., Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund Ltd., Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.